Friday, March 6, 2020 / 10:40 AM / NSE / Header
Image Credit: Vanguard
This is to notify the General Public that the Board of Directors of GlaxoSmithKline Consumer Nigeria Plc (the Company) will meet on Friday 13th March 2020 to consider and approve:
1. The 2019 Audited Financial Statements
2. The amount to be recommended to members as dividend at the next Annual General Meeting and
3. Fix the date and venue of the Annual General Meeting.
The General Public will be informed of the Board's decisions immediately after the meeting.
The General Public should take note that the closed period for dealing in the Company's securities by the Directors, Managers or connected persons shall commence from Tuesday 3rd March 2020 and shall terminate 24 hours after release of the result to the Nigerian Stock Exchange.
Visit GlaxoSmithKline Consumer Nigeria Plc IR Page in Proshare MARKETS
Graph - One Year Share Price Movement
Table: Unaudited Q3 2019 Results